MT1-MMP regulates MMP-2 expression and angiogenesis-related functions in human umbilical vein endothelial cells

Biochemical and Biophysical Research Communications

Volumn 437, Issue 2, 2013, Pages 232-238

  Lee, Hsinyu ^a   Chang, Kai Wei ^a   Yang, Hsi Yuan ^a   Lin, Po Wei ^a   Chen, Shee Uan ^b   Huang, Yuan Li ^c  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c ASIA UNIVERSITY   (Taiwan)

Author keywords

Angiogenesis; HUVECs; MMP 2; MT1 MMP

Indexed keywords

GELATINASE A; MATRIX METALLOPROTEINASE 14; SMALL INTERFERING RNA; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ANGIOGENESIS; ARTICLE; CELL ADHESION; CELL FUNCTION; CONTROLLED STUDY; DOWN REGULATION; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; UMBILICAL VEIN ENDOTHELIAL CELL; WESTERN BLOTTING;

ANGIOGENESIS; HUVECS; MMP-2; MT1-MMP;

CELLS, CULTURED; ENDOTHELIUM, VASCULAR; HUMANS; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE 2; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; UMBILICAL VEINS;

EID: 84880709359     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.06.046     Document Type: Article

References (34)

1. Murphy G., Nagase H. Localizing matrix metalloproteinase activities in the pericellular environment. FEBS J. 2011, 278:2-15.
2. Nagase H., Visse R., Murphy G. Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc. Res. 2006, 69:562-573.
3. Visse R., Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ. Res. 2003, 92:827-839.
4. Hadler-Olsen E., Fadnes B., Sylte I., Uhlin-Hansen L., Winberg J.O. Regulation of matrix metalloproteinase activity in health and disease. FEBS J. 2011, 278:28-45.
5. Hayashidani S., Tsutsui H., Ikeuchi M., Shiomi T., Matsusaka H., Kubota T., Imanaka-Yoshida K., Itoh T., Takeshita A. Targeted deletion of MMP-2 attenuates early LV rupture and late remodeling after experimental myocardial infarction. Am. J. Physiol. Heart Circ. Physiol. 2003, 285:H1229-1235.
6. Matsumura S., Iwanaga S., Mochizuki S., Okamoto H., Ogawa S., Okada Y. Targeted deletion or pharmacological inhibition of MMP-2 prevents cardiac rupture after myocardial infarction in mice. J. Clin. Invest. 2005, 115:599-609.
7. Wu W.T., Chen C.N., Lin C.I., Chen J.H., Lee H. Lysophospholipids enhance matrix metalloproteinase-2 expression in human endothelial cells. Endocrinology 2005, 146:3387-3400.
8. Strongin A.Y., Collier I., Bannikov G., Marmer B.L., Grant G.A., Goldberg G.I. Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease. J. Biol. Chem. 1995, 270:5331-5338.
9. Zitka O., Kukacka J., Krizkova S., Huska D., Adam V., Masarik M., Prusa R., Kizek R. Matrix metalloproteinases. Curr. Med. Chem. 2010, 17:3751-3768.
10. Jo Y., Yeon J., Kim H.J., Lee S.T. Analysis of tissue inhibitor of metalloproteinases-2 effect on pro-matrix metalloproteinase-2 activation by membrane-type 1 matrix metalloproteinase using baculovirus/insect-cell expression system. Biochem. J. 2000, 345(Pt 3):511-519.
11. Genis L., Gonzalo P., Tutor A.S., Galvez B.G., Martinez-Ruiz A., Zaragoza C., Lamas S., Tryggvason K., Apte S.S., Arroyo A.G. Functional interplay between endothelial nitric oxide synthase and membrane type 1 matrix metalloproteinase in migrating endothelial cells. Blood 2007, 110:2916-2923.
12. Langlois S., Gingras D., Beliveau R. Membrane type 1-matrix metalloproteinase (MT1-MMP) cooperates with sphingosine 1-phosphate to induce endothelial cell migration and morphogenic differentiation. Blood 2004, 103:3020-3028.
13. Sato H., Takino T., Miyamori H. Roles of membrane-type matrix metalloproteinase-1 in tumor invasion and metastasis. Cancer Sci. 2005, 96:212-217.
14. Seiki M. Membrane-type 1 matrix metalloproteinase: a key enzyme for tumor invasion. Cancer Lett. 2003, 194:1-11.
15. Seiki M. The cell surface: the stage for matrix metalloproteinase regulation of migration. Curr. Opin. Cell Biol. 2002, 14:624-632.
16. D'Alessio S., Ferrari G., Cinnante K., Scheerer W., Galloway A.C., Roses D.F., Rozanov D.V., Remacle A.G., Oh E.S., Shiryaev S.A., Strongin A.Y., Pintucci G., Mignatti P. Tissue inhibitor of metalloproteinases-2 binding to membrane-type 1 matrix metalloproteinase induces MAPK activation and cell growth by a non-proteolytic mechanism. J. Biol. Chem. 2008, 283:87-99.
17. Koo B.H., Kim Y.H., Han J.H., Kim D.S. Dimerization of matrix metalloproteinase-2 (MMP-2): functional implication in MMP-2 activation. J. Biol. Chem. 2012, 287:22643-22653.
18. Langlois S., Di Tomasso G., Boivin D., Roghi C., Murphy G., Gingras D., Beliveau R. Membrane type 1-matrix metalloproteinase induces endothelial cell morphogenic differentiation by a caspase-dependent mechanism. Exp. Cell Res. 2005, 307:452-464.
19. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat. Med. 2000, 6:389-395.
20. Carmeliet P., Jain R.K. Angiogenesis in cancer and other diseases. Nature 2000, 407:249-257.
21. Bottos A., Bardelli A. Oncogenes and angiogenesis: a way to personalize anti-angiogenic therapy?. Cell. Mol. Life Sci. 2013.
22. Kalluri R. Basement membranes: structure, assembly and role in tumour angiogenesis. Nat. Rev. Cancer 2003, 3:422-433.
23. Lapidot T., Dar A., Kollet O. How do stem cells find their way home?. Blood 2005, 106:1901-1910.
24. Kudo Y., Iizuka S., Yoshida M., Tsunematsu T., Kondo T., Subarnbhesaj A., Deraz E.M., Siriwardena S.B., Tahara H., Ishimaru N., Ogawa I., Takata T. Matrix metalloproteinase-13 (MMP-13) directly and indirectly promotes tumor angiogenesis. J. Biol. Chem. 2012, 287:38716-38728.
25. Tang Y., Rowe R.G., Botvinick E.L., Kurup A., Putnam A.J., Seiki M., Weaver V.M., Keller E.T., Goldstein S., Dai J., Begun D., Saunders T., Weiss S.J. MT1-MMP-dependent control of skeletal stem cell commitment via a beta1-integrin/YAP/TAZ signaling axis. Dev. Cell. 25(4) 2013, 402-416.
26. Sakai K., Nakamura T., Suzuki Y., Imizu T., Matsumoto K. 3-D collagen-dependent cell surface expression of MT1-MMP and MMP-2 activation regardless of integrin beta1 function and matrix stiffness. Biochem. Biophys. Res. Commun. 2011, 412:98-103.
27. Wu H.L., Lin C.I., Huang Y.L., Chen P.S., Kuo C.H., Chen M.S., Wu G.C., Shi G.Y., Yang H.Y., Lee H. Lysophosphatidic acid stimulates thrombomodulin lectin-like domain shedding in human endothelial cells. Biochem. Biophys. Res. Commun. 2008, 367:162-168.
28. Takino T., Saeki H., Miyamori H., Kudo T., Sato H. Inhibition of membrane-type 1 matrix metalloproteinase at cell-matrix adhesions. Cancer Res. 2007, 67:11621-11629.
29. Langlois S., Nyalendo C., Di Tomasso G., Labrecque L., Roghi C., Murphy G., Gingras D., Beliveau R. Membrane-type 1 matrix metalloproteinase stimulates cell migration through epidermal growth factor receptor transactivation. Mol. Cancer Res. 2007, 5:569-583.
30. Rozanov D.V., Savinov A.Y., Williams R., Liu K., Golubkov V.S., Krajewski S., Strongin A.Y. Molecular signature of MT1-MMP: transactivation of the downstream universal gene network in cancer. Cancer Res. 2008, 68:4086-4096.
31. Onguchi T., Han K.Y., Chang J.H., Azar D.T. Membrane type-1 matrix metalloproteinase potentiates basic fibroblast growth factor-induced corneal neovascularization. Am. J. Pathol. 2009, 174:1564-1571.
32. Hotary K.B., Allen E.D., Brooks P.C., Datta N.S., Long M.W., Weiss S.J. Membrane type I matrix metalloproteinase usurps tumor growth control imposed by the three-dimensional extracellular matrix. Cell 2003, 114:33-45.
33. Droppelmann C.A., Gutierrez J., Vial C., Brandan E. Matrix metalloproteinase-2-deficient fibroblasts exhibit an alteration in the fibrotic response to connective tissue growth factor/CCN2 because of an increase in the levels of endogenous fibronectin. J. Biol. Chem. 2009, 284:13551-13561.
34. Yan L., Moses M.A., Huang S., Ingber D.E. Adhesion-dependent control of matrix metalloproteinase-2 activation in human capillary endothelial cells. J. Cell Sci. 2000, 113(Pt. 22):3979-3987.